Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseE. Sidransky, Andrew Singleton, José Brás et al.|New England Journal of Medicine|2009Cited by 2.1k
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's diseaseOwen A. Ross, Ruey‐Meei Wu, Yih‐Ru Wu et al.|Annals of Neurology|2008Cited by 194
Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s DiseaseYa‐Jen Chiu, Guey‐Jen Lee‐Chen|International Journal of Molecular Sciences|2023Cited by 25
Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau CytotoxicityChih‐Hsin Lin, Guey‐Jen Lee‐Chen|Biomolecules & Therapeutics|2022Cited by 14